Related Experiment Videos
The case for therapeutic vaccines
1Division of Oncology, Department of Cellular and Molecular Sciences, St. George's Hospital Medical School, London, UK.
Melanoma Research
|February 1, 1996
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid.
Clinical and experimental immunology·2022
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
An approach for automatic classification of grouper vocalizations with passive acoustic monitoring.
The Journal of the Acoustical Society of America·2018
Mechanisms of action of tasquinimod on the tumour microenvironment.
Cancer chemotherapy and pharmacology·2013
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
An online cutaneous melanoma risk screen tool.
Melanoma research·2026
The role of circulating tumor DNA in the management of melanoma: a literature review.
Melanoma research·2026
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026